This inventor holds 8 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2003-2022.
Company Filing History:
Years Active: 2003-2022
Title: Innovations by Inventor Boyd Yount in Dengue Virus Research
Introduction: Boyd Yount is a distinguished inventor based in Hillsborough, NC, known for his significant contributions to the field of virology. Holding a total of 8 patents, his pioneering work focuses primarily on developing methods and compositions for addressing dengue virus challenges, with an emphasis on vaccine development.
Latest Patents: Among Boyd Yount's latest patents, two stand out prominently. The first patent, titled "Methods and compositions for dengue virus serotype 4 epitopes," introduces innovative compositions and methods of use involving a chimeric dengue virus E glycoprotein. This invention features a dengue virus E glycoprotein backbone that includes amino acid substitutions aimed at integrating an epitope from a different dengue virus serotype than that of the backbone. His second patent, "Methods and compositions for dengue virus vaccines," similarly presents unique methodologies and compositions featuring the chimeric dengue virus E glycoprotein, designed to incorporate an epitope recognized by an antibody from a diverse dengue virus serotype.
Career Highlights: Boyd Yount's career is marked by his dedication to virology and vaccine research. Associating consistently with the University of North Carolina at Chapel Hill, he has been instrumental in advancing the understanding of dengue virus serotypes and enhancing vaccine efficacy through innovative methodologies. His contributions significantly impact public health responses to viral outbreaks.
Collaborations: Boyd Yount collaborates with esteemed colleagues in his research endeavors. Notably, he works closely with Ralph Baric and Douglas Widman, both of whom are recognized for their expertise and contributions within the virology community. This collaboration fosters an environment of innovation and shared knowledge, further propelling advancements in dengue virus research.
Conclusion: Boyd Yount's innovative spirit and dedication to scientific advancement underscore his role as a key contributor to the field of virology. Through his patents and collaborations, he is making strides towards developing effective dengue virus vaccines, benefitting both the scientific community and public health initiatives.